Turn Therapeutics TTRX
NASDAQ TTRX
$10.11 +0.19 (+1.92%)
As of: Nov 11, 2026 · 9:30 AM EST

Turn Therapeutics (TTRX) Invested Capital (2026)

Updated

Turn Therapeutics (TTRX) reported Invested Capital of $6.75 million for Q2 2026, down 44.0% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Invested Capital (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 126.18 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 76.32 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 45.14 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 39.27 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 151.97 Bn
10 Turn Therapeutics 303.28 Mn 266.54 Mn - 11.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 11.88 Mn
Jun 30, 2026 6.75 Mn
Mar 31, 2026 12.05 Mn
API Access

Turn Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=TTRX&period=max&api_key=YOUR_API_KEY